Home
/

What is a Thyroid antibodies Blood Test?

REVIEWED BY
Bill Maish, MD
Clinical Content Consultant
Published
May 30, 2026
Last updated
May 30, 2026
Quick answer:

Thyroid antibodies are immune proteins that mistakenly attack the thyroid's own proteins—thyroid peroxidase (anti-TPO), thyroglobulin (anti-Tg), and TSH receptor (TRAb)—revealing autoimmune activity. Anti-TPO and anti-Tg are associated with Hashimoto's inflammation and predict hypothyroidism progression, while TRAb can drive hyperthyroidism (Graves') or block function. Combined with TSH and free T4/T3, the antibody panel helps differentiate autoimmune patterns and may help support tracking of long-term metabolic, fertility, and cardiovascular risks.

Read more →
Table of contents

Thyroid Antibodies: The Three Autoimmune Signals to the Gland

Thyroid antibodies are immune proteins in the blood that recognize and attach to parts of the thyroid gland. They are made by B cells when the immune system mistakenly targets the thyroid’s own proteins. The main types are directed against thyroid peroxidase and thyroglobulin, which are enzyme and storage proteins inside the gland, and against the thyroid‑stimulating hormone receptor on thyroid cells (anti‑TPO, anti‑Tg, and TSH receptor antibodies/TRAb). These antibodies circulate in the bloodstream and show how the adaptive immune system is interacting with thyroid tissue (autoantibodies, immunoglobulins).

Their significance is that they reveal autoimmune activity affecting the thyroid. Anti‑TPO and anti‑Tg antibodies signal immune‑driven inflammation in the gland and are linked to tissue injury and shifts in hormone production (thyroiditis). TSH receptor antibodies can bind the receptor and either drive it or block it, changing how much hormone the gland makes (stimulating or blocking TRAb/TSI). In short, thyroid antibody testing shows whether the immune system is targeting the thyroid, helps identify the autoimmune nature of a thyroid problem, and can appear before changes in standard thyroid hormones, providing context for symptoms and future risk.

Why an Antibody Panel Distinguishes Hashimoto's From Graves'

Thyroid antibody testing reveals whether the immune system is targeting the thyroid’s own proteins—most often thyroid peroxidase (TPO), thyroglobulin (Tg), or the TSH receptor (TRAb). Because the thyroid sets the body’s metabolic pace, immune activity here can ripple through energy, weight, heart rhythm, temperature control, mood, fertility, pregnancy, bone, and growth in children.

Big picture, thyroid antibodies link immune dysregulation to endocrine control. They help explain abnormal TSH/T4 results, refine risk in borderline cases, and inform monitoring of cardiovascular, skeletal, reproductive, pregnancy, and developmental health over time.

How the Antibody Panel Reads Across Negative and Positive

Results are usually reported as negative/positive or as titers against a lab cutoff. The healthiest pattern is undetectable or negative antibodies. When values are negative or very low, they reflect immune tolerance: thyroid tissue is not being attacked, hormone production remains steady, and symptoms are absent. This pattern is common in men and many women; in pregnancy it’s associated with lower risk of thyroid dysfunction and adverse outcomes.

When antibodies are elevated, they mark autoimmune thyroid disease. High TPO or Tg antibodies point to Hashimoto’s tendency, which can precede a rise in TSH and later hypothyroidism—fatigue, cold intolerance, weight gain, dry skin, constipation, heavy periods; cholesterol may rise, heart rate slow, and a goiter can develop. In children, slowed growth and school difficulties may emerge. High TRAb signals Graves’ biology, often with hyperthyroidism—weight loss, heat intolerance, tremor, palpitations, anxiety, eye changes; risks include bone loss and atrial fibrillation. Titers can fluctuate, but higher levels increase the chance of progression or relapse.

What Affects Thyroid Antibody Readings

Notes: Assay methods and cutoffs vary; titers fluctuate and do not always mirror disease activity. Acute illness, iodine exposure, immune‑modulating drugs (for example interferon or amiodarone), and the postpartum period can unmask antibodies. Coexisting autoimmune disease and family history raise prevalence.

What an Antibody Profile Adds to Thyroid Risk Assessment

A thyroid antibodies blood test measures immune proteins against thyroid components—typically thyroid peroxidase (TPOAb), thyroglobulin (TgAb), and sometimes TSH‑receptor antibodies (TRAb/TSI). These are markers of autoimmune activity, not hormones. Their pattern signals whether the immune system is targeting the thyroid, which can change hormone supply and, in turn, energy, metabolism, heart rhythm, cognition, mood, menstrual cycles, fertility, and pregnancy outcomes.

Low values usually reflect no detectable thyroid‑directed autoimmunity and intact immune tolerance. Thyroid function is more likely governed by gland output and pituitary feedback. Across ages and sexes, low/negative antibodies are common; in pregnancy they imply lower risk of autoimmune thyroiditis. Negative antibodies do not exclude non‑autoimmune thyroid disorders.

Being in range suggests immunologic stability around the thyroid and predictable hormone status. For most assays, within reference ranges sits near zero or below the lab cutoff, especially with normal TSH and free T4.

High values usually reflect autoimmune thyroid disease. Elevated TPOAb/TgAb indicate chronic lymphocytic thyroiditis (Hashimoto’s) and a higher likelihood of developing hypothyroidism over time. Elevated TRAb/TSI points to Graves’ disease and a tendency toward hyperthyroidism; rarely, blocking TRAb causes hypothyroidism. In pregnancy, TRAb can cross the placenta and affect fetal or neonatal thyroid; maternal TPOAb is linked to higher risk of miscarriage and postpartum thyroiditis. In youth, antibodies may precede overt dysfunction.

FAQs

Thyroid antibodies are immune proteins that mistakenly target and attack the thyroid gland. The main types include thyroid peroxidase antibodies (TPOAb), thyroglobulin antibodies (TgAb), and TSH receptor antibodies (TRAb/TSI). Their presence indicates autoimmune thyroid disease, such as Hashimoto’s thyroiditis or Graves’ disease. Detecting these antibodies helps clarify the cause of symptoms like fatigue, weight changes, or palpitations, and can flag a higher risk of future thyroid dysfunction even when TSH and free T4 levels are normal. Monitoring thyroid antibodies is crucial for guiding treatment, especially in borderline or unstable thyroid cases, and for protecting fertility and pregnancy outcomes.

Thyroid antibodies signal immune activity against the thyroid, which can disrupt hormone production. In Hashimoto’s thyroiditis, elevated TPOAb or TgAb can lead to hypothyroidism, causing fatigue, weight gain, constipation, and cold intolerance. In Graves’ disease, high TRAb/TSI levels drive hyperthyroidism, resulting in palpitations, weight loss, anxiety, tremor, and heat intolerance. Even before hormone levels change, the presence of antibodies can explain symptoms and help predict future thyroid issues.

TPO antibodies (TPOAb) target thyroid peroxidase, an enzyme essential for thyroid hormone production. Thyroglobulin antibodies (TgAb) attack thyroglobulin, a protein used to store thyroid hormones. TSH receptor antibodies (TRAb/TSI) bind to the TSH receptor; some stimulate it (causing hyperthyroidism in Graves’ disease), while others block it (leading to hypothyroidism). Each antibody type is associated with different autoimmune thyroid conditions and helps guide diagnosis and management.

Thyroid antibody testing is important for fertility and pregnancy because thyroid autoimmunity increases the risk of miscarriage, subfertility, and postpartum thyroiditis. Elevated TPOAb or TgAb in women planning pregnancy or already pregnant can prompt closer monitoring of TSH and thyroid hormone levels, tighter treatment targets, and more frequent follow-up. Negative or low antibody levels are associated with lower risk of pregnancy complications and better reproductive outcomes.

Thyroid antibodies can be elevated years before changes in TSH or free T4 appear. This early immune activity signals a higher risk of developing thyroid dysfunction in the future, even if current hormone levels are normal. Monitoring antibody trends helps guide the timing of treatment and follow-up, especially in people with borderline thyroid function or symptoms suggestive of thyroid disease.

Superpower currently offers at-home blood testing in the following states: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, and Wisconsin.

We’re actively expanding nationwide, with new states being added regularly. If your state isn’t listed yet, stay tuned.

References

  1. Caturegli, P., De Remigis, A., & Rose, N. R. (2014). Hashimoto thyroiditis: Clinical and diagnostic criteria. Autoimmunity Reviews, 13(4-5), 391-397. https://doi.org/10.1016/j.autrev.2014.01.007
  2. Vanderpump, M. P., Tunbridge, W. M., French, J. M., Appleton, D., Bates, D., Clark, F., Grimley Evans, J., Hasan, D. M., Rodgers, H., & Tunbridge, F. (1995). The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickham Survey. Clinical Endocrinology, 43(1), 55-68. https://doi.org/10.1111/j.1365-2265.1995.tb01894.x
  3. Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., & Walter, M. A. (2016). 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid, 26(10), 1343-1421. https://doi.org/10.1089/thy.2016.0229
  4. Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber, K. A. (2012). Clinical practice guidelines for hypothyroidism in adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid, 22(12), 1200-1235. https://doi.org/10.1089/thy.2012.0205
  5. Koulouri, O., Moran, C., Halsall, D., Chatterjee, K., & Gurnell, M. (2013). Pitfalls in the measurement and interpretation of thyroid function tests. Best Practice & Research. Clinical Endocrinology & Metabolism, 27(6), 745-762. https://doi.org/10.1016/j.beem.2013.10.003

Built by the world’s top doctors and scientists

Dr Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

Learn more

Dr Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

Learn more

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

Learn more

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

Learn more
Membership slide 1
Membership slide 1
Membership slide 2
Membership slide 3
1 / 3

Your membership starts here

Annual 100+ biomarker panel

Data dashboard and digital twin

Upload past labs and connect wearables

Personalized health protocol

24/7 care team access

AI companion for all health questions

Marketplace with additional solutions

$199

/year*

Billed annually

HSA/ FSA eligible
Cancel anytime
Results in a week

* Pricing may vary for members in New York and New Jersey